REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > (o=)n(=o)-o-c Containing (e.g., Nitrate Ester, Etc.) > Cyano Or Isocyano Bonded Directly To Carbon > Z-c(=o)-o-y, Wherein Z Contains A Benzene Ring Z-c(=o)-o-y, Wherein Z Contains A Benzene RingZ-c(=o)-o-y, Wherein Z Contains A Benzene Ring patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.06/22/06 - 20060135604 - Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use together with a pharmaceutically acceptable carrier or excipient, wherein the compound of formula (1) is present in polymorphic Form A (see, e.g., FIG. 6) substantially free of other polymorphic forms. ... 06/08/06 - 20060122269 - Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments The invention provides compositions and methods to inhibit the cell cycle G2 checkpoint, in particular the DNA-damage-induced G2 checkpoint, in mammalian cells including human cells. Specifically, the invention provides compositions and methods to sensitize cells to DNA-damaging agents by abrogating the cell cycle G2 checkpoint. Compounds of the invention are ... 04/27/06 - 20060089409 - Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid These compounds exhibited 5-Lipoxigenase inhibitory properties and these compounds may be used in pharmaceutical compositions for therapeutic applications against a variety of inflammations and hypersensitivity-based human diseases including asthma, arthritis, bowel diseases such as ulcerative colitis and circulatory disorders such as shock and ischaemia. These compounds also inhibited the growth ... // - 27. R1═OH, R2═H R3═COOH, R4& R5═OH & H - ... // - 26. R1═OCOCH3, R2═H R3═CN, R4 & R5═O - ... // - 25. R1═OCOCH3, R2═H R3═NH2, R4 & R5═O - ... // - 24. R1═OCOCH3, R2═H R3═NCO, R4 & R5═O - ... // - 23. R1═OCOCH3, R2═H, R3═CON(CH2CH2)2NH, R4 & R5═O - ... // - 22. R1═OCOCH3, R2═H, R3═CONHCH2CH2OH, R4 & R5═O - ... // - 21. R1═OCOCH3, R2═H, R3═CONHCH2CH2NH2, R4 & R5═O - ... // - 20. R1═OCOCH3, R2═H, R3═CONHNH2, R4 & R5═O - ... // - 19. R1═OCOCH3, R2═H R3═CONH2, R4 & R5═O - ... // - 18. R1═OCOCH3, R2═H R3═COOCH2CH2N(CH3)2, R4 & R5═O - ... // - 17. R1 & R2═H & OCOCH3 R3═H, R4 & R5═O - ... // - 16. R1 & R2═N(OH), R3═COOCH3, R4 & R5═O - ... // - 15. R1═SH, R2═H, R3═COOCH3, R4& R5═O - ... // - 14. R1═CN, R2═H, R3═COOCH3, R4 & R5═O - ... // - 13. R1═H, R2═Br, R3 COOCH3, R4 & R5═O - ... // - 12. R1═H, R2═OH, R3═COOCH3, R4 & R5═O - ... // - 11. R1═OCOCH(CH3)NH2HCl, R2═H, R3═COOH, R4 & R5═O - ... // - 10. R1═OCOCH2NH2HCl, R2═H, R3—COOH, R4 & R5═O - ... // - 9. R1═OCOCH2NH(tert-BOC), R2═H, R3═COOCH3, R4 & R5═O - ... // - 8. R1=3′,4′-Dihydroxy-5′-methoxycinnamoyloxy, R2═H, R3 COOH, R4 & R5═O - ... // - 7. R1=3′,4′-Dimethoxycinnamoyloxy, R2═H, R3═COOH, R4 & R5═O - ... // - 6. R1=4′-Hydroxycinnamoyloxy, R2═H, R3═COOH, R4 & R5═O - ... // - 5. R1=8′,9′-Dihydro-4′-hydroxycinnamoyloxy, R2═H, R3═COOH, R4 & R5═O - ... // - 4. R1═OCOCH2CH2COOH, R2═H, R3═COOH, R4 & R5═O - ... // - 3. R1=5′-O-methylgalloyloxy, R2═H, R3═COOH, R4 & R5═O - ... // - 2. R1═OCOCH2Cl, R2═H, R3═COOH, R4 & R5═O - ... // - 1. R1═OCHO, R2═H, R3═COOH, R4 & R5═O - ... 03/09/06 - 20060052445 - Diarylsulfones as 5-ht2a antagonists are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS. ... 02/16/06 - 20060035968 - Composition for preventing cancer comprising 2'-benzoyl-oxycinnamaldehyde Disclosed is a composition for preventing cancer comprising a compound represented by Chemical Formula 1, 2′-benzoyloxycinnamaldehyde (BCA). BCA has the effects of delaying tumor incidence and increasing immune cells in a transgenic mouse overexpressing H-ras oncogene playing a critical role in tumor cell growth. Thus, BCA is useful as a ... 12/29/05 - 20050288368 - Compositions and methods for treating and preventing necrosis A method for treating and/or preventing cell necrosis and diseases associated therewith, comprising the inhibition of one or more elastase enzymes within said cells. ... 10/27/05 - 20050239882 - Pharmaceutical compositions useful in prevention and treatment of beta-amyloid protien-induced disease The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the invention relates to the use of natural product compounds isolated from turmeric, gingko biloba, ... 10/06/05 - 20050222257 - Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation wherein n, Y, R1, R1a, R2 and R2a are as defined in claim 1. ... 09/15/05 - 20050203179 - Use of hydroxydiphenyl ether derivatives as arylsulfatase-inhibitors in deodorants and antiperspirants The invention relates to the use of selected hydroxydiphenyl ether derivatives as arylsulfatase-inhibiting substances in a cosmetic deodorant or antiperspirant composition for reducing body odor caused by decomposition of steroid esters. ... 09/08/05 - 20050197393 - Pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the invention relates to the use of natural product compounds isolated from turmeric, gingko biloba, ... 07/28/05 - 20050165095 - Disubstituted chalcone oximes having rary retinoid receptor antagonist activity where the variables have the values described in the specification are antagonists of RARγ retinoid receptors. ... 06/30/05 - 20050143457 - Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative The present invention provides a novel crystalline form of n-butyl[4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl) benzenesulfonylamino]ethyl]-2′-methanesulfonyl-3-yloxy] acetate hydrochloride, pharmaceutical compositions containing the same and their uses, which exhibits excellent inhibitory activities against activated blood coagulation factor X, and is useful for the treatment or prevention of a tromboembolic disease. ... ### FreshPatents.com Support |